Novalgen logo
VerifiedBiotechnology· Founded 2019

Novalgen

NovalGen is an innovative immuno-oncology company developing breakthrough bispecific therapies that can safely harness the immune system to fight cancer. NovalGen is focused on the development of cutting-edge, proprietary treatments for patients with hematologic malignancies and solid tumors by developing therapeutics that treat cancer using our breakthrough technologies in Bispecific antibodies and beyond

7-day free trial · no credit card

HeadquartersMiddlesex, United KingdomEmployees13(11 to 50)Founded year2019Websitenovalgen.comLinkedIn profileLinkedIn

Verified contacts

12

available on Kipplo

LinkedIn employees

13

11 to 50 range

Open roles

no listings

Distinct roles

11

indexed titles

Tech stack

0

tools in use

Monthly traffic

organic / mo

Sign up free to see all 12 verified contacts at Novalgen

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

12 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Novalgen

11 distinct titles indexed · top 10 shown.

  • 1account assistant
  • 1associate director (promoted from senior scientist in cmc)
  • 1associate director, translational biology
  • 1chief operating officer & chief technical officer
  • 1director strategy & competitive intelligence
  • 1director, biology
  • 1personal assistant to chief executive officer
  • 1research technician
  • 1senior scientist
  • 1team leader cmc - cell banking and upstream processing (senior scientist)
  • +1more titles

Sign up to unlock all 12 contacts at Novalgen

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 12 verified contacts at Novalgen

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Novalgen | Kipplo Discover